Cullinan Associates’s Tenet Healthcare THC Stock Holding History

Cullinan Associates’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,900	Closed	-$411K	–	228
2021 Q1	$411K	Buy	+7,900	New	+$399K	0.02%	170

Other funds holding THC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Cullinan Associates's THC Position: Q2 2021 in Review

Cullinan Associates sold out of Tenet Healthcare (THC) in Q2 2021, closing a stake of 7,900 shares — an estimated $411K sold.

Cullinan Associates first reported a position in THC in Q1 2021 and held it in 1 quarter. The position peaked at $411K in Q1 2021. 322 funds tracked by Wall St. Rank hold THC as of Q2 2021.

Cullinan Associates reported no remaining Tenet Healthcare position as of Q2 2021 after selling out during the quarter.
Cullinan Associates sold 7,900 Tenet Healthcare shares in Q2 2021, an estimated $411K.
Cullinan Associates first reported a position in Tenet Healthcare in Q1 2021 and held it in 1 quarter.
Cullinan Associates's Tenet Healthcare position peaked at $411K in Q1 2021.
322 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2021.

Based on Cullinan Associates's 13F filing for Q2 2021, filed 7 Jul 2021.